Author

Jonathon Kaiser

Institution: PTC Therapeutics (United States)

Observed institution: PTC Therapeutics (United States)

OpenAlex ID: A5113374584

J003 PIVOT-LTE: a Phase 2, double-blind, randomized extension study to evaluate the long-term safety and efficacy of PTC518 in participants with Huntington’s disease

2024 · Brian Beers, Amy-Lee Bredlau, et al.

J002 Twelve-month interim data from PIVOT-HD: a Phase 2, randomized, placebo-controlled study to evaluate the safety and efficacy of PTC518 in participants with Huntington’s disease

2024 · Amy-Lee Bredlau, Brian Beers, et al.

Works count: 2

Citation count:

H-index:

I10-index: